![Ocular Therapeutix, Inc. logo](/logos/OCUL.webp)
Ocular Therapeutix, Inc.
NASDAQ:OCUL
Overview | Financials
Company Name | Ocular Therapeutix, Inc. |
Symbol | OCUL |
Currency | USD |
Price | 8.39 |
Market Cap | 1,308,185,580 |
Dividend Yield | 0% |
52-week-range | 1.995 - 11.31 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Antony Mattessich |
Website | https://www.ocutx.com |
An error occurred while fetching data.
About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD